974
Index
Antiviral agents
continued
herpes and cytomegalovirus, 132–134
adverse effects, 133
care considerations, 134
contraindications and cautions, 133
cytomegalovirus (CMV), definition,
126, 132
cytomegalovirus immunoglobulin,
286
drug–drug interactions, 133–134
herpes, definition, 126, 132
pharmacokinetics, 133
therapeutic actions and indications,
132
HIV and AIDS, 126, 128
agents for, 127, 134–144
care considerations, 142
CCR5 coreceptor antagonist, 126,
136, 141
critical thinking scenario, 143–144
education, 138
fixed combination drugs, 139
fusion inhibitor, 126, 136, 140
integrase inhibitor, 126, 136, 141–142
non-nucleoside reverse transcriptase
inhibitors, 126, 136
nucleoside reverse transcriptase
inhibitors, 126, 136–139
protease inhibitors, 126, 136,
139–140
influenza A and respiratory viruses,
126, 127, 130–132
adverse effects, 131
care considerations, 131–132
contraindications and cautions,
130–131
drug–drug interactions, 131
pharmacokinetics, 130
therapeutic actions and
contraindications, 129, 130
locally active, 127, 146–147
adverse effects, 147
care considerations, 147
contraindications and cautions, 147
therapeutic actions and indications,
146
older adults, 128
Anxiety, 303, 304
Anxiolytic and hypnotic agents, 303–313
adults, 304
barbiturates used as anxiolytic/
hypnotics, 310–312
adverse effects, 311
care considerations, 312
contraindications and cautions, 311
drug–drug interactions, 311–312
pharmacokinetics, 310
therapeutic actions and indications,
310
benzodiazepines used as anxiolytics,
305–310
adverse effects, 307
care considerations, 307–308
contraindications and cautions,
306–307
drug–drug interactions, 307
pharmacokinetics, 306
therapeutic actions and indications,
306
children, 304
miscellaneous drugs, 312–313
antihistamines, 313
buspirone, 313
chloral hydrate, 313
dexmedetomidine, 313
promethazine, 313
trimeprazine, 313
zolpidem, 313
zopicione, 313
older adults, 304
states affected by, 304–305
anxiety, 303, 304
hypnosis, 303, 305
sedation, 303, 304–305
Apixaban, 756, 759–760
Apomorphine, 374–376
Apple, 962
Apraclonidine, 956
Aprepitant, 199, 929, 932, 935
Arachidonic acid, 228, 231
ARC (AIDS-related complex), 126, 135
Aripiprazole, 335, 336, 338, 344, 345
Arnica, 962
Arrhythmias, 642, 647–648, 697–699
agents for.
See
Antiarrhythmic agents
atrial, 698–699, 708
atrioventricular block, 648
automaticity, 697
conductivity, 697
haemodynamics, 697–698
sinus, 647–648
supraventricular, 648
types, 698–699
ventricular, 648, 699–701, 708
Arsenic trioxide, 195, 222
Artemether-lumefantrine 167
Arteries, 642, 643
Arthritis.
See
Antiarthritis agents
Ascaris
, 179, 180, 181
Ashwagandha, 962
Aspirin, 240–245, 751, 755, 758–759
Assessment, 42, 43–45
education level and understanding, 44
financial supports, 44
healthcare pattern, 44
history, 44
physical examination, 44–45
physical parameters, 45
social supports, 44
Asthma, 834, 839
Astragalus, 962
Atazanavir, 136, 139
Atelectasis, 834, 838
Atenolol, 469, 482–483, 675
Atheromas, 713, 714
Atherosclerosis, 713, 714
Atomoxetione, 347
Atorvastatin, 729, 734, 736, 737,
740–741
Atovaquone, 172, 173
Atracurium, 434, 435, 437
Atrial arrhythmias, 698–699, 708
Atrioventricular block, 648
Atrium, 642, 643
Atropine, 501–503, 506–507, 956
atropine-like (anticholinergic) effects,
38
toxicity, 506
Attention-deficit disorders, 334, 336, 347
Auditory damage, 37–38
Auranofin, 252, 253
Auricle, 642, 643
Australian Drug Evaluation Committee
(ADEC)
drugs in pregnancy, classification, 9
Australian Prescriber
, 12
Autism
MMR vaccine and, 278
Autoimmune disease, 228, 238
Automaticity, 642, 644–645, 697
Autonomic nervous system, 444–453
adrenergic agonists.
See
Adrenergic
agonists
adrenergic blocking agents.
See
Adrenergic blocking agents
anticholinergic agents.
See
Anticholinergic agents
cholinergic agonists.
See
Cholinergic
agonists
function, 445–446
nerve impulse transmission, 445
parasympathetic nervous system, 444,
450–452
acetylcholine release, 451, 452
acetylcholine synthesis and storage,
451
blockade, effects, 505
cholinergic receptors, 451, 452
cholinergic response, 450–452
muscarinic receptors, 444, 451
nicotinic receptors, 444, 451
structure and function, 450
termination of response, 452
structure, 445–446
sympathetic nervous system, 444,
446–450
adrenergic receptors, 448
adrenergic response, 447–449
alpha-receptors, 444, 448
beta-receptors, 444, 448
blockers, 675–676
noradrenaline release, 448
noradrenaline synthesis and storage,
447–448
structure and function, 446–447
termination of response, 449
Autonomy, 190, 191
Axons, 292, 293, 295
Azacitidine, 200
Azathioprine, 260, 263, 264
Azelaic acid, 953
Azelastine, 853, 854, 953, 956
Azithromycin, 103, 122
Azole antifungals, 150, 151–157
adverse effects, 154
contraindications and cautions, 154
drug–drug interactions, 154
pharmacokinetics, 153–154
